Abstract
We report the discovery of a CTX-M-15-producing Escherichia coli (STEC) of serogroup O111:H8, a major serotype responsible for human enterohemorrhagic Escherichia coli (EHEC) infections. In line with the recent CTX-M-15/O104:H4 E. coli outbreak, these data may reflect an accelerating spread of resistance to expanded-spectrum cephalosporins within the E. coli population, including STEC isolates.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Bacterial Agents / pharmacology
-
Cephalosporins / pharmacology
-
Escherichia coli Infections / microbiology
-
Humans
-
Serotyping
-
Shiga-Toxigenic Escherichia coli / enzymology*
-
Shiga-Toxigenic Escherichia coli / genetics
-
Shiga-Toxigenic Escherichia coli / isolation & purification
-
beta-Lactam Resistance
-
beta-Lactamases / genetics
-
beta-Lactamases / metabolism*
Substances
-
Anti-Bacterial Agents
-
Cephalosporins
-
beta-lactamase CTX-M-15
-
beta-Lactamases